Who are LENSAR, Inc.'s main suppliers?

LENSAR, Inc. (LNSR) key suppliers include: WELLS-FARGO-BANK-N-A, SUPPLIERS, CHINA, GERMANY, SOUTH-KOREA and 4 more. View the full supplier network at chainsifter.com/chain/LNSR.

Who are LENSAR, Inc.'s major customers?

LENSAR, Inc. (LNSR) key customers include: ASCS, HOSPITALS, PHYSICIANS, PDL-BIOPHARMA-INC, Bausch Health Companies Inc. and 3 more. View the full customer network at chainsifter.com/chain/LNSR.

What sector is LENSAR, Inc. in?

LENSAR, Inc. (LNSR) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

LNSR Supply Chain: LENSAR, Inc. Supplier List & 19 Relationships

9Suppliers

8Customers

2Debt Items

20Related Chains

LENSAR, Inc. Suppliers

Ticker	Name	Confidence	Evidence
WELLS-FARGO-BANK-N-A	WELLS-FARGO-BANK-N-A	92%	The PCL Agreement provides for a revolving, non-purpose margin credit facility, secured by a first-priority lien on a designated brokerage account maintained at Wells Fargo
SUPPLIERS	SUPPLIERS	85%	We purchase custom and off-the-shelf components from a number of suppliers, including some single-source suppliers.
CHINA	CHINA	80%	we sell our products through distributor relationships
GERMANY	GERMANY	80%	we sell our products through distributor relationships
SOUTH-KOREA	SOUTH-KOREA	80%	we sell our products through distributor relationships
BHC	Bausch Health Companies Inc.	72%	zation efforts will provide us with significant opportunity for future growth as we continue to penetrate existing and new markets. Our ALLY System currently is cleared for marketing in the United St…
BHC	Bausch Health Companies Inc.	72%	Reciprocal relationship from BHC graph: Reciprocal relationship from LNSR graph: zation efforts will provide us with significant opportunity for future growth as we continue to penetrate existing and…
JNJ	Johnson & Johnson	72%	zation efforts will provide us with significant opportunity for future growth as we continue to penetrate existing and new markets. Our ALLY System currently is cleared for marketing in the United St…
JNJ	Johnson & Johnson	72%	Reciprocal relationship from JNJ graph: Reciprocal relationship from LNSR graph: zation efforts will provide us with significant opportunity for future growth as we continue to penetrate existing and…

LENSAR, Inc. Customers

Ticker	Name	Confidence	Evidence
ASCS	ASCS	90%	we and our distributors typically market and sell our systems to ASCs, hospitals and physicians
HOSPITALS	HOSPITALS	90%	we and our distributors typically market and sell our systems to ASCs, hospitals and physicians
PHYSICIANS	PHYSICIANS	90%	we and our distributors typically market and sell our systems to ASCs, hospitals and physicians
PDL-BIOPHARMA-INC	PDL-BIOPHARMA-INC	85%	185 Total 2,756 2,872 Less accumulated depreciation ( 2,385 ) ( 2,381 ) Construction in progress 293 188 Property and equipment, net $ 664 $ 679 Depreciation expense on property and equipment amounte…
BHC	Bausch Health Companies Inc.	72%	zation efforts will provide us with significant opportunity for future growth as we continue to penetrate existing and new markets. Our ALLY System currently is cleared for marketing in the United St…
BHC	Bausch Health Companies Inc.	72%	Reciprocal relationship from BHC graph: Reciprocal relationship from LNSR graph: Reciprocal relationship from BHC graph: Reciprocal relationship from LNSR graph: zation efforts will provide us with s…
JNJ	Johnson & Johnson	72%	zation efforts will provide us with significant opportunity for future growth as we continue to penetrate existing and new markets. Our ALLY System currently is cleared for marketing in the United St…
JNJ	Johnson & Johnson	72%	Reciprocal relationship from JNJ graph: Reciprocal relationship from LNSR graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from LNSR graph: zation efforts will provide us with s…

LENSAR, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
LNSR-DEBT-10744	Warrants outstanding: 10338000	90%	xbrl warrant detail from xbrl 2025-12-31.
LNSR-DEBT	Debt stack $2.6M	90%	Market cache reports total debt of $2.6M.

LENSAR, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for LENSAR, Inc..

LENSAR, Inc. Ownership

Holder	Name	Confidence	Evidence
LNSR-OWNER-BRANDES-INVESTMENT-PARTNERS-LP	BRANDES INVESTMENT PARTNERS, LP	90%	13F overlay lists BRANDES INVESTMENT PARTNERS, LP as top holder; 88 tracked holders.

LENSAR, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
BCAX	Bicara Therapeutics Inc.	100.00	2
ACIU	AC Immune SA	100.00	2
CLGN	CollPlant Biotechnologies Ltd.	100.00	2
BLCO	Bausch + Lomb Corporation	100.00	1	['receiving']
TRIB	Trinity Biotech plc	100.00	2
ABBV	AbbVie Inc.	100.00	2
BLLN	BillionToOne, Inc.	100.00	2
ATRA	Atara Biotherapeutics, Inc.	100.00	2
CYTOF	Altamira Therapeutics Ltd.	100.00	2
BNR	Burning Rock Biotech Limited	100.00	2
BNRG	Brenmiller Energy Ltd	100.00	2
ANIK	Anika Therapeutics, Inc.	100.00	2
CSTE	Caesarstone Ltd.	100.00	2
ADGM	Adagio Medical Holdings, Inc.	100.00	2
SNNUF	Smith & Nephew plc	100.00	2
AORT	Artivion, Inc.	100.00	2
ALC	Alcon Inc.	100.00	2
AVBP	ArriVent BioPharma, Inc.	100.00	2
BHC	Bausch Health Companies Inc.	100.00	1	['customer', 'supplier']
AURA	Aura Biosciences, Inc.	100.00	2

LENSAR, Inc. Supply Chain